Adaptive Biotechnologies Corporation ADPT

$ 6.0 -1.8%

Quarterly report 2024-Q3
added 11-07-2024

Adaptive Biotechnologies Corporation Balance Sheet 2011-2025 | ADPT

Annual Balance Sheet Adaptive Biotechnologies Corporation

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	75 M	44.6 M	-27.3 M	-	-60 M	-55 M	-85.3 M	-	-	-	-	-	-
Long Term Debt	131 M	125 M	107 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	9.38 M	9.23 M	5.06 M	3.53 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	263 M	568 M	566 M	-	-	-	-	-	-
Total Current Liabilities	88 M	110 M	114 M	105 M	78.3 M	-	-	-	-	-	-	-	-
Total Liabilities	353 M	393 M	319 M	373 M	341 M	591 M	587 M	-	-	-	-	-	-
Deferred Revenue	48.6 M	64.1 M	80.5 M	73.3 M	61 M	12.7 M	14 M	-	-	-	-	-	-
Retained Earnings	-1.14 B	-919 M	-719 M	-512 M	-365 M	-296 M	-249 M	-	-	-	-	-	-
Total Assets	661 M	857 M	923 M	1.12 B	912 M	333 M	362 M	-	-	-	-	-	-
Cash and Cash Equivalents	65.1 M	90 M	139 M	123 M	96.6 M	-	-	-	-	-	-	-	-
Book Value	308 M	464 M	604 M	743 M	571 M	-258 M	-225 M	-	-	-	-	-	-
Total Shareholders Equity	308 M	464 M	604 M	743 M	571 M	-258 M	-225 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Adaptive Biotechnologies Corporation

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	133 M	132 M	132 M	131 M	127 M	94.2 M	96.5 M	125 M	101 M	-	105 M	107 M	108 M	104 M	95.3 M	104 M	104 M	104 M	104 M	36.6 M	36.6 M	36.6 M	36.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	335 M	343 M	346 M	353 M	356 M	369 M	368 M	393 M	396 M	-	305 M	319 M	341 M	340 M	346 M	373 M	373 M	373 M	373 M	341 M	341 M	341 M	341 M	29.9 M	29.9 M	29.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	51.9 M	52.2 M	46.9 M	48.6 M	55.3 M	57.9 M	60.3 M	64.1 M	67.9 M	-	83.5 M	80.5 M	80 M	83.6 M	78.3 M	73.3 M	73.3 M	73.3 M	73.3 M	61 M	61 M	61 M	61 M	12.7 M	12.7 M	12.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.27 B	-1.24 B	-1.19 B	-1.14 B	-1.07 B	-1.02 B	-977 M	-919 M	-879 M	-	-782 M	-719 M	-657 M	-602 M	-552 M	-512 M	-512 M	-512 M	-512 M	-365 M	-365 M	-365 M	-365 M	-296 M	-296 M	-296 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	559 M	585 M	620 M	661 M	718 M	765 M	791 M	857 M	884 M	-	858 M	923 M	993 M	1.03 B	1.07 B	1.12 B	1.12 B	1.12 B	1.12 B	912 M	912 M	912 M	912 M	333 M	333 M	333 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	38.1 M	59.8 M	71.2 M	65.1 M	88.7 M	109 M	94.6 M	90 M	218 M	-	115 M	139 M	122 M	184 M	174 M	123 M	123 M	123 M	123 M	96.6 M	96.6 M	96.6 M	96.6 M	55 M	55 M	55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	224 M	241 M	275 M	308 M	362 M	396 M	424 M	464 M	488 M	-	553 M	604 M	652 M	693 M	726 M	743 M	743 M	743 M	743 M	571 M	571 M	571 M	571 M	303 M	303 M	303 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	224 M	242 M	275 M	308 M	362 M	396 M	424 M	464 M	488 M	518 M	553 M	604 M	652 M	693 M	726 M	743 M	743 M	743 M	743 M	571 M	571 M	571 M	571 M	-258 M	-258 M	-258 M	-234 M	-225 M	-	-	-	-190 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency